John Palma

John Palma

Company: Agilent Technologies

Job title: Vice President, Head of Global Medical Affairs

Seminars:

Panel Discussion & Q&A: The Role of Liquid Biopsy in Enabling Development of Biomarker-driven Targeted Therapies 6:35 pm

Evolving landscape of biomarker testing across tumour types Discovering actionable mechanisms of resistance in liquid biopsy Leveraging continued advances in liquid biopsy’s accessibility and accuracy to advance novel biomarker discoRead more

day: The Role of Liquid Biopsy in Enabling Development of Biomarker-driven Targeted Therapies

Opening Remarks & Introduction 6:30 pm

Read more

day: The Role of Liquid Biopsy in Enabling Development of Biomarker-driven Targeted Therapies

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.